Indices | Group 1, n = 63 | Group 2, n = 121 | Group 3, n = 99 |
Follow-up period | 2 yrs. | 2 yrs. | 4 yrs. |
Management approach | Surgical | Sparing | Sparing |
Operated, including stent-graft implantation | 56 (88.9%) | 17 (14.0%) | 24 (24.2%) |
6 | 8 | 8 | |
Non-operated, including due to severity of | 7 (11.1%) | 104(86.0%) | 75 (75.8%) |
the disease | 7 (11.1%) | 29 (24.0%) | 22 (22.2%) |
Mortality rate among operated pts., | 8(14.3%) | 1 (0.83%) | 5 (20.8%) |
including that not associated with the operation | 4 (7.14%) | - | 3 (12.5%) |
Mortality rates among non-operated pts. | 5 (71.4%) | 11 (10.6%) | 18 (24%) |
Mortality rate due to aneurysm rupture, | 4 (6.35%) | 4 (3.3%) | 8 (8.1%) |
- Among operated pts. on aorta | 2 (3.57%) | - | 2 (8.3%) |
- Among non-operated pts. | 2 (28.6%) | 4 (3.85%) | 6 (8%) |
Mortality rate due to other diseases, | 7 (11.1%) | 7 (5.8%) | 13 (13.1%) |
- Among operated pts. on aorta | 4 (7.14%) | - | 1 (4.2%) |
- Among non-operated pts. | 3 (42.86%) | 7 (6.7%) | 12 (16%) |
All-cause mortality | 13 (20.6%) | 12 (9.92%) | 23 (23.2%) |